ABCB1 and acute myeloid leukemia: Several studies analyzed the influence of ABCB1 polymorphisms in AML patients treated with anthracyclines, finding conflicting results, as some studies showed higher response or survival rates in patients carrying some variant alleles [51,60,61,62]; in contrast, other works did not confirm or even contradicted these associations [50,63,64,65,66].